In vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy

Molecular Pharmaceutics

Volumn 11, Issue 2, 2014, Pages 638-644

  Yu, Cui Yun ^a   Wang, Yan Mei ^a   Li, Na Mei ^a   Liu, Ge Sha ^a   Yang, Sa ^a   Tang, Guo Tao ^a   He, Dong Xiu ^a   Tan, Xiang Wen ^a   Wei, Hua ^b  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b University of Washington   (United States)

Author keywords

5 FU; ASGPR; drug delivery system; hepatocellular carcinoma; pectin nanoparticles

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; CALCIUM ION; FLUOROURACIL; GALACTOSE; NANOPARTICLE; PECTIN; ANTINEOPLASTIC AGENT; MICROCAPSULE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; CELL STRAIN HEPG2; CELL SURFACE; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG POTENCY; DRUG TARGETING; EVALUATION STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; ANIMAL; BIOASSAY; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; IC50; LIVER NEOPLASMS; MICROCAPSULE; MOUSE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; CAPSULES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HUMANS; INHIBITORY CONCENTRATION 50; LIVER NEOPLASMS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; PECTINS; RATS;

EID: 84893229164     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400412c     Document Type: Article

References (39)

1. Lord, R.; Suddle, A.; Ross, P. J. Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies IJCP 2011, 65 (2) 182-188
2. Garcia, M. G.; Bayo, J.; Bolontrade, M. F.; Sganga, L.; Malvicini, M.; Alaniz, L.; Aquino, J. B.; Fiore, E.; Rizzo, M. M.; Rodriguez, A.; Lorenti, A.; Andriani, O.; Podhajcer, O.; Mazzolini, G. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo Mol. Pharmaceutics 2011, 8 (5) 1538-1548
3. Cheng, M. R.; He, B.; Wan, T.; Zhu, W. P.; Han, J.; Zha, B. B.; Chen, H. X.; Yang, F. X.; Li, Q.; Wang, W.; Xu, H. Z.; Ye, T. 5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model PLoS One 2012, 7 (10) e47115 10.1371/journal. pone.0047115
4. Wilson, B.; Ambika, T. V.; Patel, R. D.; Jenita, J. L.; Priyadarshini, S. R. Nanoparticles based on albumin: Preparation, characterization and the use for 5-flurouracil delivery Int. J. Biol. Macromol. 2012, 51, 874-878
5. Nagai, H.; Matsui, T.; Kanayama, M.; Momiyama, K.; Shizawa, K.; Wakui, N.; Shinohara, M.; Watanabe, M.; Iida, K.; Ishii, K.; Igarashi, Y.; Sumino, Y. Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinoma Cancer Chemother. Pharmacol. 2010, 66, 1123-1129
6. Peters, G. J.; van der Wilt, C. L.; van Triest, B.; Codacci-Pisanelli, G.; Johnston, P. G.; van Groeningen, C. J.; Pinedo, H. M. Thymidylate synthase and drug resistance Eur. J. Cancer 1995, 31, 1299-1305
7. Kodama, Y.; Fumoto, S.; Nishi, J.; Nakashima, M.; Sasaki, H.; Nakamura, J. Absorption and distribution characteristics of 5-fluorouracil (5-FU) after an application to the liver surface in rats in order to reduce systemic side effects Biol. Pharm. Bull. 2008, 31 (5) 1049-1052 (Pubitemid 351732011)
8. Wettergren, Y.; Carlsson, G.; Odin, E.; Gustavsson, B. Pretherapeutic uracil and dihydrouracil levels of colorectal cancer patients are associated with sex and toxic side effects during adjuvant 5-fluorouracil-based chemotherapy Cancer 2012, 118, 2935-2943
9. Cooke, J. W. B.; Bright, R.; Coleman, M. J.; Jenkins, K. P. Process research and development of a dihydropyrimidine dehydrogenase inactivator: large-scale preparation of eniluracil using a sonogashira coupling Org. Process Res. Dev. 2001, 5, 383-386
10. Lowery, A.; Onishko, H.; Hallahan, D. E.; Han, Z. Z. Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors J. Controlled Release 2004, 100, 275-292
11. Acharya, S.; Sahoo, S. K. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect Adv. Drug Delivery Rev. 2011, 63, 170-183
12. Danhier, F.; Feron, O.; Préat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Controlled Release 2010, 148, 135-146
13. Cosco, D.; Paolino, D.; Muzzalupo, R.; Celia, C.; Citraro, R.; Caponio, D.; Picci, N.; Fresta, M. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil Biomed. Microdevices 2009, 11 (5) 1115-1125
14. Yik, J. H.; Saxena, A.; Weigel, P. H. The minor subunit splice variants, H2b and H2c, of the human asialoglycoprotein receptor are present with the major subunit H1 in different hetero-oligomeric receptor complexes Biol. Chem. 2002, 27, 23076-23083 (Pubitemid 34967294)
15. Fallon, R. J.; Danaher, M.; Saxena, A. The asialoglycoprotein receptor is associated with a tyrosine kinase in HepG2 cells J. Biol. Chem. 1994, 269, 26626-26629 (Pubitemid 24332849)
16. Mu, J. Z.; Gordon, M.; Shao, J. S.; Aloers, D. H. Apical expression of functional asialogly- coprotein receptor in the human intestinal cell line HT-29 Gastroenterology 1997, 113 (5) 1501-1509 (Pubitemid 27461236)
17. Diaz, C.; Vargas, E.; Gatijens, B. O. Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines Int. J. Pharm. 2006, 325 (1/2) 1082-115
18. Felix, K. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles J. Controlled Release 2008, 132, 171-183
19. Nakabayashi, H.; Taketa, K.; Miyano, K.; Yamane, T.; Sato, J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium Cancer Res. 1982, 42 (9) 3858-3862
20. Das, R. K.; Kasoju, N.; Bora, U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells Nano: NBM 2010, 6, 153-160
21. Ernsting, M. J.; Tang, W. L.; MacCallum, N. W.; Li, S. D. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models Biomaterials 2012, 33, 1445-1454
22. Manconi, M.; Nácher, A.; Merino, V.; Merino-Sanjuan, M.; Manca, M. L.; Mura, C.; Mura, S.; Fadda, A. M.; Diez-Sales, O. Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation AAPS PharmSciTech 2013, 14 (2) 485-96
23. Mura, C.; Nácher, A.; Merino, V.; Merino-Sanjuán, M.; Manconi, M.; Loy, G.; Fadda, A. M.; Díez-Sales, O. Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery Colloids Surf., B 2012, 94, 199-205
24. Hiwale, P.; Lampis, S.; Conti, G.; Caddeo, C.; Murgia, S.; Fadda, A. M.; Monduzzi, M. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium Biomacromolecules 2011, 12 (9) 3186-93
25. Mura, C.; Nácher, A.; Merino, V.; Merino-Sanjuan, M.; Carda, C.; Ruiz, A.; Manconi, M.; Loy, G.; Fadda, A. M.; Diez-Sales, O. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats Int. J. Pharm. 2011, 416 (1) 145-54
26. Manconi, M.; Mura, S.; Manca, M. L.; Fadda, A. M.; Dolz, M.; Hernandez, M. J.; Casanovas, A.; Díez-Sales, O. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization Int. J. Pharm. 2010, 392 (1-2) 92-100
27. Yu, C. Y.; Cao, H.; Zhang, X. C.; Zhou, F. Z.; Cheng, S. X.; Zhang, X. Z.; Zhuo, R. X. Hybrid Nanospheres and vesicles based on pectin as drug carriers Langmuir 2009, 25 (19) 11720-11726
28. Yu, C. Y.; Jia, L. H.; Yin, B. C.; Zhang, X. Z.; Cheng, S. X.; Zhuo, R. X. Fabrication of nanospheres and vesicles as drug carriers by self-assembly of alginate J. Phys. Chem. C 2008, 112, 16774-16778
29. Yu, C. Y.; Jia, L. H.; Cheng, S. X.; Zhang, X. Z.; Zhuo, R. X. Fabrication of microparticle protein delivery systems based on calcium alginate J. Microencapsulation 2010, 27 (2) 171-177
30. Yu, C. Y.; Wei, H.; Zhang, Q.; Zhang, X. Z.; Cheng, S. X.; Zhuo, R. X. Effect of ions on the aggregation behavior of natural polymer alginate J. Phys. Chem. B 2009, 113, 14839-14843
31. Yu, C. Y.; Yin, B. C.; Zhang, W.; Cheng, S. X.; Zhang, X. Z.; Zhuo, R. X. Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property Colloids Surf., B 2009, 68, 245-249
32. Yu, C. Y.; Zhang, X. C.; Zhou, F. Z.; Zhang, X. Z.; Cheng, S. X.; Zhuo, R. X. Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems Int. J. Pharm. 2008, 357, 15-21
33. Jabbari, E. Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles Pharm. Res. 2009, 26, 11095-008-9802-1
34. Ackland, S. P.; Garg, M. B.; Dunstan, R. H. Simultaneous determination of dihydrofluorouracil and 5-fluorouracil in plasma by high-performance liquid chromatography Anal. Biochem. 1997, 246 (1) 79-85 (Pubitemid 27100510)
35. Liang, H. F.; Chen, C. T.; Chen, S. C.; Kulkarni, A. R.; Chiua, Y. L.; Chen, M. C. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticlesas a targeted drug delivery system for the treatment of liver cancer Biomaterials 2006, 27, 2051-2059 (Pubitemid 41759499)
36. Wang, D.; Monika, S.; Mosley, R. L.; Davda, J. P.; Tietze, N.; Miller, S. C.; Gwilt, P. R.; Kopečková1, P.; Kopeček, J. Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl) methacrylamide (HPMA) copolymers Mol. Pharmaceutics 2006, 3 (6) 717-725 (Pubitemid 46087487)
37. Pankaj, V.; Chen, Y.; Kholodovych, V.; Welsh, W.; Stein, S.; Sinko, P. J. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation J. Controlled Release 2004, 100 (2) 275-292 (Pubitemid 39491279)
38. He, W.; Du, Q.; Cao, D. Y.; Xiang, B.; Fan, L. F. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats Int. J. Pharm. 2008, 348, 35-45 (Pubitemid 350266237)
39. Dong, Y. C.; Feng, S. S. In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy Biomaterials 2007, 28, 4154-4160